Prophylactic agent, ameliorating agent, and therapeutic agent for dry eye
AssigneeTsubota Laboratory, Inc.
InventorEmi Nishimura
Life of this patent
Estimating the term…
Abstract
The present disclosure pertains to provision of: a tear layer stabilizer; a prophylactic agent, ameliorating agent, and therapeutic agent for corneal epithelial disorders; a prophylactic agent, ameliorating agent, and therapeutic agent for meibomian gland dysfunction; and a prophylactic agent, ameliorating agent, and therapeutic agent for dry eye. More specifically, provided are a tear layer stabilizer, a prophylactic agent, ameliorating agent, and therapeutic agent for corneal epithelial disorders, and a prophylactic agent, ameliorating agent, and therapeutic agent for meibomian gland dysfunction, and a prophylactic agent, ameliorating agent, and therapeutic agent for dry eye, each of which composition contains apocynin as an active ingredient.
Claims12
A method of treating a meibomian gland dysfunction in a subject in need thereof, the method comprising topically administering to an eye of the subject a topical ophthalmic composition comprising apocynin as an active ingredient, wherein the topical ophthalmic composition comprises the apocynin at a concentration of 0.001% (w/v) to 0.1% (w/v).
Dependencies are inferred from the claim text.